Perspectives in diabetes

Aldose reductase catalysis and crystallography: Insights from recent advances in enzyme structure and function

J. Mark Petrash, Ivan Tarle, David K. Wilson, Florante A. Quiocho

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Enhanced metabolism of glucose via the polyol pathway may play an important role in the pathogenesis of diabetic retinopathy, neuropathy, and nephropathy. Aldose reductase catalyzes the NADPH-dependent conversion of glucose to sorbitol, the first step in the polyol pathway. Interruption of the polyol pathway by inhibition of aldose reductase holds considerable promise as a therapeutic measure to prevent or delay the onset and severity of these late complications of diabetes. Dramatic advances in our understanding of the molecular biology, enzymology, and three-dimensional structure of aldose reductase have occurred in recent years, providing new and challenging insights into the enzyme's catalytic mechanism. Recent developments in structure determination of aldose reductase and the implications for evaluation and development of aldose reductase inhibitors are summarized.

Original languageEnglish (US)
Pages (from-to)955-959
Number of pages5
JournalDiabetes
Volume43
Issue number8
StatePublished - 1994
Externally publishedYes

Fingerprint

Aldehyde Reductase
Crystallography
Catalysis
Enzymes
Glucose
Sorbitol
Diabetic Neuropathies
Diabetic Nephropathies
Diabetic Retinopathy
Diabetes Complications
NADP
Molecular Biology
polyol

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Perspectives in diabetes : Aldose reductase catalysis and crystallography: Insights from recent advances in enzyme structure and function. / Petrash, J. Mark; Tarle, Ivan; Wilson, David K.; Quiocho, Florante A.

In: Diabetes, Vol. 43, No. 8, 1994, p. 955-959.

Research output: Contribution to journalArticle

Petrash, J. Mark ; Tarle, Ivan ; Wilson, David K. ; Quiocho, Florante A. / Perspectives in diabetes : Aldose reductase catalysis and crystallography: Insights from recent advances in enzyme structure and function. In: Diabetes. 1994 ; Vol. 43, No. 8. pp. 955-959.
@article{6e6c653bcb3e45bea90e08f0c649a933,
title = "Perspectives in diabetes: Aldose reductase catalysis and crystallography: Insights from recent advances in enzyme structure and function",
abstract = "Enhanced metabolism of glucose via the polyol pathway may play an important role in the pathogenesis of diabetic retinopathy, neuropathy, and nephropathy. Aldose reductase catalyzes the NADPH-dependent conversion of glucose to sorbitol, the first step in the polyol pathway. Interruption of the polyol pathway by inhibition of aldose reductase holds considerable promise as a therapeutic measure to prevent or delay the onset and severity of these late complications of diabetes. Dramatic advances in our understanding of the molecular biology, enzymology, and three-dimensional structure of aldose reductase have occurred in recent years, providing new and challenging insights into the enzyme's catalytic mechanism. Recent developments in structure determination of aldose reductase and the implications for evaluation and development of aldose reductase inhibitors are summarized.",
author = "Petrash, {J. Mark} and Ivan Tarle and Wilson, {David K.} and Quiocho, {Florante A.}",
year = "1994",
language = "English (US)",
volume = "43",
pages = "955--959",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - Perspectives in diabetes

T2 - Aldose reductase catalysis and crystallography: Insights from recent advances in enzyme structure and function

AU - Petrash, J. Mark

AU - Tarle, Ivan

AU - Wilson, David K.

AU - Quiocho, Florante A.

PY - 1994

Y1 - 1994

N2 - Enhanced metabolism of glucose via the polyol pathway may play an important role in the pathogenesis of diabetic retinopathy, neuropathy, and nephropathy. Aldose reductase catalyzes the NADPH-dependent conversion of glucose to sorbitol, the first step in the polyol pathway. Interruption of the polyol pathway by inhibition of aldose reductase holds considerable promise as a therapeutic measure to prevent or delay the onset and severity of these late complications of diabetes. Dramatic advances in our understanding of the molecular biology, enzymology, and three-dimensional structure of aldose reductase have occurred in recent years, providing new and challenging insights into the enzyme's catalytic mechanism. Recent developments in structure determination of aldose reductase and the implications for evaluation and development of aldose reductase inhibitors are summarized.

AB - Enhanced metabolism of glucose via the polyol pathway may play an important role in the pathogenesis of diabetic retinopathy, neuropathy, and nephropathy. Aldose reductase catalyzes the NADPH-dependent conversion of glucose to sorbitol, the first step in the polyol pathway. Interruption of the polyol pathway by inhibition of aldose reductase holds considerable promise as a therapeutic measure to prevent or delay the onset and severity of these late complications of diabetes. Dramatic advances in our understanding of the molecular biology, enzymology, and three-dimensional structure of aldose reductase have occurred in recent years, providing new and challenging insights into the enzyme's catalytic mechanism. Recent developments in structure determination of aldose reductase and the implications for evaluation and development of aldose reductase inhibitors are summarized.

UR - http://www.scopus.com/inward/record.url?scp=0028037576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028037576&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 955

EP - 959

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -